RadNet (RDNT, Care providers & labs) Stock Valuation & Fair Value
Significantly overvaluedRadNet (RDNT, Care providers & labs) trades at a current P/E of 152.6, about 171% above its historical normal valuation, with a forward growth estimate of 50.8% and a PEG of 3.00. Analysts' one-year estimates have been hit 10% of the time. Priced at its historical normal P/E of 56.2 on the same blended earnings, the 2026-11-06 close of $76.00 corresponds to about $28.00 a share. This is a valuation reference, not a price target.
How to read these numbers: the PEG ratio and current P/E versus normal P/E.
- Price $76.00 at the Nov 6 close, 5.2% above the 20-day average ($72.21) and 4.7% above the 50-day ($72.57).
- RSI (14) at 58.1.
- 52-week range $51.87 to $84.48: the price is 10.0% below the high and 46.5% above the low.
The Street vs SeerForecast
Wall Street's mean price target for RDNT is $94.62 across 8 analysts, 24.5% above the current price. The average analyst rating is Strong Buy. Our SeerForecast read of the same stock, formed without analyst targets: significantly overvalued. When the two disagree, start your digging there.
Valuation flags
- Long-term debt is over half its capital (61%)
- Overvalued by 171%
- Misses analyst estimates often (80%)
Verdict history
tickerseer's rating has been significantly overvalued since 2026-08-07.
Not every point was recorded live. Points marked recalculated are worked out from the metrics tickerseer archived that week.
Selected weeks: the first, the latest, and the cheapest and dearest.
Show all 27 readings
Frequently asked questions
Is RadNet stock overvalued?
At a current P/E of 152.6 versus its historical normal P/E of 56.2, RadNet trades about 171% above its typical valuation, with a PEG of 3.00 on 50.8% forward growth. tickerseer currently rates it significantly overvalued.
What is RadNet's fair value and PEG?
RadNet trades at a current P/E of 152.6 against a historical normal P/E of 56.2, a PEG of 3.00, and a forward growth estimate of 50.8%. Priced at its historical normal P/E of 56.2 on the same blended earnings, the 2026-11-06 close of $76.00 corresponds to about $28.00 a share. This is a valuation reference, not a price target.
Has tickerseer's rating of RadNet changed?
tickerseer's rating has been significantly overvalued since 2026-08-07.
What is the analyst price target for RadNet?
The mean Wall Street price target for RadNet is $94.62 across 8 analysts, 24.5% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.
Industry: Care providers & labs. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and an AI research note where we have one. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.